Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplantation Lymphoproliferative Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Early research (Phase 1)Looking for participantsNCT03533816
What this trial is testing

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
University of Kansas Medical Center 38
Early research (Phase 1)Study completedNCT01497184
What this trial is testing

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 95
Early research (Phase 1)Ended earlyNCT05065047
What this trial is testing

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05317416
What this trial is testing

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

Who this might be right for
Multiple Myeloma
Pfizer 854
Testing effectiveness (Phase 2)Study completedNCT05338047
What this trial is testing

Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

Who this might be right for
Myeloma MultipleLymphoma
Hospital Universitario Dr. Jose E. Gonzalez 30
Testing effectiveness (Phase 2)Looking for participantsNCT04746209
What this trial is testing

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-Cell ALL, Childhood
Medical College of Wisconsin 25
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00134017
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142
Testing effectiveness (Phase 2)Study completedNCT02362997
What this trial is testing

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL

Who this might be right for
Hodgkin LymphomaDiffuse Large B Cell LymphomaPeripheral T-Cell Lymphoma
Dana-Farber Cancer Institute 82
Testing effectiveness (Phase 2)Study completedNCT00795886
What this trial is testing

Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
University of Utah 63
Not applicableStudy completedNCT00507260
What this trial is testing

Nutritional Assessment Intervention to Improve Cancer-Related Fatigue

Who this might be right for
LeukemiaLymphomaFatigue
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)WithdrawnNCT05820763
What this trial is testing

Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant

Who this might be right for
Multiple MyelomaMyeloma-Associated Amyloidosis
Washington University School of Medicine
Not applicableStudy completedNCT02182986
What this trial is testing

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Who this might be right for
Heart TransplantSmall Intestine TransplantKidney Transplant+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 944
Not applicableNot Yet RecruitingNCT07746232
What this trial is testing

Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

Who this might be right for
Multiple Myeloma (MM)
Fondazione EMN Italy Onlus 92
Testing effectiveness (Phase 2)Ended earlyNCT01434472
What this trial is testing

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Who this might be right for
Post-Transplant Lymphoproliferative DisorderRecurrent Adult Diffuse Large Cell LymphomaRecurrent B-Cell Non-Hodgkin Lymphoma+4 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT02799147
What this trial is testing

GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid LeukemiaMixed-Lineage Acute Leukemias
St. Petersburg State Pavlov Medical University 27
Large-scale testing (Phase 3)Ended earlyNCT00003152
What this trial is testing

Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 469
Testing effectiveness (Phase 2)Active Not RecruitingNCT03315026
What this trial is testing

Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis

Who this might be right for
Multiple MyelomaAL Amyloidosis
Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Looking for participantsNCT03326921
What this trial is testing

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Who this might be right for
Juvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more
Fred Hutchinson Cancer Center 24
Next Page